Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengshen Wang

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cancer Reports (Hoboken, N.J.)|August 9, 2024
IBSP Promotes Breast Cancer Bone Metastasis and Proliferation via BMP-SMAD Signaling PathwayWei Ding, Di Lv, Mengshen Wang, et al.
Journal of Multidisciplinary Healthcare|July 14, 2026
Multicenter Validation of an Integrated DCE-MRI Radiomics, Deep Learning, and S-II Model for Predicting Axillary Lymph Node Metastasis in Breast CancerXinxin Lu, Mengshen Wang, Xiaohua Liu, et al.
Current Osteoporosis Reports|January 11, 2024
The Role of Breast Cancer Cells in Bone Metastasis: Suitable Seeds for Nourishing SoilYiou Wang, Yue Hu, Mozhi Wang, et al.
Journal of Multidisciplinary Healthcare|July 8, 2026
Interpretable Dynamic MRI-ITH Model for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer: A Multicenter StudyMengshen Wang, Xiaohua Liu, Wei Ding, et al.
Cancer Biology & Medicine|July 2, 2024
ACSL3 regulates breast cancer progression <i>via</i> lipid metabolism reprogramming and the YES1/YAP axisShirong Tan, Xiangyu Sun, Haoran Dong, et al.
Journal of Breast Cancer|January 4, 2020
Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant ChemotherapyXinyan Li, Mozhi Wang, Mengshen Wang, et al.
Translational Cancer Research|February 4, 2022
Can ACEI/ARB prevent the cardiotoxicity caused by chemotherapy in early-stage breast cancer?-a meta-analysis of randomized controlled trialsHaoran Dong, Litong Yao, Mozhi Wang, et al.
Frontiers in Oncology|April 17, 2020
Metabolic Reprogramming in Triple-Negative Breast CancerXiangyu Sun, Mozhi Wang, Mengshen Wang, et al.
Frontiers in Cell and Developmental Biology|August 15, 2020
Exploring the Metabolic Vulnerabilities of Epithelial-Mesenchymal Transition in Breast CancerXiangyu Sun, Mozhi Wang, Mengshen Wang, et al.
Journal of Breast Cancer|September 10, 2020
Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast CancerXinyan Li, Litong Yao, Mozhi Wang, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cancer Reports (Hoboken, N.J.)|August 9, 2024
IBSP Promotes Breast Cancer Bone Metastasis and Proliferation via BMP-SMAD Signaling PathwayWei Ding, Di Lv, Mengshen Wang, et al.
Journal of Multidisciplinary Healthcare|July 14, 2026
Multicenter Validation of an Integrated DCE-MRI Radiomics, Deep Learning, and S-II Model for Predicting Axillary Lymph Node Metastasis in Breast CancerXinxin Lu, Mengshen Wang, Xiaohua Liu, et al.
Current Osteoporosis Reports|January 11, 2024
The Role of Breast Cancer Cells in Bone Metastasis: Suitable Seeds for Nourishing SoilYiou Wang, Yue Hu, Mozhi Wang, et al.
Journal of Multidisciplinary Healthcare|July 8, 2026
Interpretable Dynamic MRI-ITH Model for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer: A Multicenter StudyMengshen Wang, Xiaohua Liu, Wei Ding, et al.
Cancer Biology & Medicine|July 2, 2024
ACSL3 regulates breast cancer progression <i>via</i> lipid metabolism reprogramming and the YES1/YAP axisShirong Tan, Xiangyu Sun, Haoran Dong, et al.
Journal of Breast Cancer|January 4, 2020
Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant ChemotherapyXinyan Li, Mozhi Wang, Mengshen Wang, et al.
Translational Cancer Research|February 4, 2022
Can ACEI/ARB prevent the cardiotoxicity caused by chemotherapy in early-stage breast cancer?-a meta-analysis of randomized controlled trialsHaoran Dong, Litong Yao, Mozhi Wang, et al.
Frontiers in Oncology|April 17, 2020
Metabolic Reprogramming in Triple-Negative Breast CancerXiangyu Sun, Mozhi Wang, Mengshen Wang, et al.
Frontiers in Cell and Developmental Biology|August 15, 2020
Exploring the Metabolic Vulnerabilities of Epithelial-Mesenchymal Transition in Breast CancerXiangyu Sun, Mozhi Wang, Mengshen Wang, et al.
Journal of Breast Cancer|September 10, 2020
Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast CancerXinyan Li, Litong Yao, Mozhi Wang, et al.
Pageof 2